Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 67 O45 | DOI: 10.1530/endoabs.67.O45

EYES2019 7th ESE Young Endocrinologists and Scientists (EYES) Meeting Oral Presentations (67 abstracts)

Antiosteoporotic drugs effectiveness and Ca/Vit D supplementations intake in elder patients with osteoporosis

L Machekhina , Yu Onuchina , E Dudinskaya , N Brailova , K Eruslanova & O Tkacheva


Russian Gerontology Research and Clinical Centre, Moscow, Russia.


Objective: To investigate osteoporosis features in elder patients in Moscow population

Materials and Methods: It was a retrospective study, during which we analyzed the data of 192 outpatients admitted to our Centre. In the focus of our attention was patients’ past medical history and T-criteria values assessed by DEXA-scan. The statistical analysis was performed using Prism 8 Version 8.0.1 (145). Statistically significant were differences with P< 0.05.

Results: Median age of the patients was 77 [73;87] years. The number of patients with 3 and more fractures was quite high and was 89. The most frequent localization of fracture was lumbar vertebras (53%). The values of T-criteria for hip and spine according to DEXA-scans showed significantly lower T-criteria (P=0,04) for lumbar vertebras vs hip: Me −3.1 [−2.6;−3.6]. 50% of the patients did not receive any antiosteoporotic treatment; treated patients received bisphosphonates in most cases (63%, n=59), followed then by denosumab (18%, n=17) and teriparatide (9%, n=8). The adverse effects were much higher in BF group (90% of all cases). Patients receiving only Ca supplementation had approximately the same prevalence of fractures compared to patients with no Ca/Vit D supplementation, meanwhile patients receiving only vitamin D had significantly lower prevalence of fractures [P=0.045], and patients receiving Ca+VitD did not differ from only Vit D-group.

Conclusion: Vitamin D and combined supplementation is extremely important in prevention of fractures, meanwhile Ca alone does not have any protective effect. In severe osteoporosis the preference should be given to anabolic treatment for better results.

Volume 67

7th ESE Young Endocrinologists and Scientists (EYES) Meeting

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.